Pediatric cancer recurrence is a significant concern for families and medical professionals alike, highlighting the ongoing battle against childhood cancers such as gliomas.Recent advancements in AI technology in pediatric oncology are paving the way for more accurate predictions regarding brain cancer relapse, potentially transforming treatment pathways for young patients.